These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 378646)

  • 1. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.
    Chew CY; Collett J; Singh BN
    Drugs; 1979 Mar; 17(3):161-81. PubMed ID: 378646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and clinical use of mexiletine.
    Fenster PE; Comess KA
    Pharmacotherapy; 1986; 6(1):1-9. PubMed ID: 3513138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical antiarrhythmic efficacy of mexiletine: a review.
    Kulbertus HE
    Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 5. Mexiletine in clinical practice.
    Boyle DM
    Acta Cardiol Suppl; 1980; (25):137-45. PubMed ID: 6990665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mexiletine in the treatment of ventricular arrhythmias.
    Henrard L; Carlier J
    Acta Cardiol Suppl; 1980; (25):127-35. PubMed ID: 6966452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of mexiletine.
    Shanks RG
    Am Heart J; 1984 May; 107(5 Pt 2):1065-71. PubMed ID: 6372422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term oral antiarrhythmic therapy with mexiletine.
    Campbell NP; Pantridge JF; Adgey AA
    Br Heart J; 1978 Jul; 40(7):796-801. PubMed ID: 687477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology, electrophysiology, and pharmacokinetics of mexiletine.
    Woosley RL; Wang T; Stone W; Siddoway L; Thompson K; Duff HJ; Cerskus I; Roden D
    Am Heart J; 1984 May; 107(5 Pt 2):1058-65. PubMed ID: 6326558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mexiletine in the management of ventricular dysrhythmias.
    Campbell NP; Pantridge JF; Adgey AA
    Eur J Cardiol; 1977 Dec; 6(4):245-58. PubMed ID: 590296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction.
    Campbell RW; Achuff SC; Pottage A; Murray A; Prescott LF; Julian DG
    J Cardiovasc Pharmacol; 1979; 1(1):43-52. PubMed ID: 94381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of intravenous and oral mexiletine in acute myocardial infarction.
    Smyllie HC; Doar JW; Head CD; Leggett RJ
    Eur J Clin Pharmacol; 1984; 26(5):537-42. PubMed ID: 6381065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mexiletine: a new type I antiarrhythmic agent.
    Schrader BJ; Bauman JL
    Drug Intell Clin Pharm; 1986 Apr; 20(4):255-60. PubMed ID: 2421992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
    Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of ventricular arrhythmias with mexiletine].
    Trenckmann H; Neugebauer A; Krosse B
    Z Gesamte Inn Med; 1982 May; 37(9):259-62. PubMed ID: 7048773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine: pharmacology and therapeutic use.
    Manolis AS; Deering TF; Cameron J; Estes NA
    Clin Cardiol; 1990 May; 13(5):349-59. PubMed ID: 2189614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative trial of mexiletine and lignocaine in the treatment of early ventricular tachyarrhythmias after acute myocardial infarction.
    Horowitz JD; Anavekar SN; Morris PM; Goble AJ; Doyle AE; Louis WJ
    J Cardiovasc Pharmacol; 1981; 3(3):409-19. PubMed ID: 6168823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of procainamide and mexiletine in prevention of ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Lancet; 1975 Jun; 1(7919):1257-60. PubMed ID: 48894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Monk JP; Brogden RN
    Drugs; 1990 Sep; 40(3):374-411. PubMed ID: 2226221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.